Description: In order to further explore the mechanisms underlying the beneficial effects of postbiotics, we conducted a randomised, double-blind, placebo-controlled crossover study. The primary efficacy indicator of our experiment was daily mean frequency of bowel movements, and the secondary outcomes were the weekly mean stool consistency score, the mean score of stool straining, the PAC-QOL, and the DASS-21. In addition, the underlying mechanism of symptom relief was revealed by analyzing the changes of gut microbes, phages, and metabolic markers in patients after postbiotic intake

Data type: Metagenome

Sample scope: Other

Release date: 2024-11-15

Last updated: 2024-11-15

Data size: 337.96GB